The global Pressurized Metered Dose Inhaler market was valued at US$ 5690.8 million in 2019 and is expected to reach US$ 7162.7 million by the end of 2026, growing at a CAGR of 3.5% during 2021-2026.
A metered-dose inhaler (MDI) is a device that delivers a specific amount of medication to the lungs, in the form of a short burst of aerosolized medicine that is usually self-administered by the patient via inhalation. It is the most commonly used delivery system for treating asthma, chronic obstructive pulmonary disease (COPD) and other respiratory diseases. The medication in a metered dose inhaler is most commonly a bronchodilator, corticosteroid or a combination of both for the treatment of asthma and COPD. Other medications less commonly used but also administered by MDI are mast cell stabilizers, such as cromoglicate or nedocromil.
The classification of Pressurized Metered Dose Inhaler includes manual type and smart type. The proportion of manual type in 2019 is about 99%. But the smart metered-dose inhaler will have a much higher growth rate in the future.
Pressurized Metered Dose Inhaler is widely used for Asthma, COPD and Others. The most proportion of Pressurized Metered Dose Inhaler used for Asthma, and the proportion in 2019 is about 48.94%.
North America is the largest market, with a market share nearly 44.49% in 2019. Following North America, Europe is the second largest sales place with the sales market share of 26.40%.
Market competition is intense. GlaxoSmithKline, Chiesi Farmaceutici S.p.A, AstraZeneca, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
Global Pressurized Metered Dose Inhaler Market: Drivers and Restrains
The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and about each type from 2016 to 2027. This section mentions the volume of production by region from 2016 to 2027. Pricing analysis is included in the report according to each type from the year 2016 to 2027, manufacturer from 2016 to 2021, region from 2016 to 2021, and global price from 2016 to 2027.
A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.
Global Pressurized Metered Dose Inhaler Market: Segment Analysis
The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027.
Key Companies profiled in this report are GlaxoSmithKline, Chiesi Farmaceutici S.p.A, AstraZeneca, Teva, Merck & Co. Inc, Boehringer Ingelheim, Mylan, Ark and more in terms of market share by sales, revenue, average pricing, product type, margins, recent developments etc.
Segment by Type
- Manual Pressurized Metered Dose Inhaler
- Smart Pressurized Metered Dose Inhaler
Segment by Application
Table of Content:
1 Pressurized Metered Dose Inhaler Market Overview
2 Pressurized Metered Dose Inhaler Market Competition by Manufacturers
3 Pressurized Metered Dose Inhaler Retrospective Market Scenario by Region
4 Global Pressurized Metered Dose Inhaler Historic Market Analysis by Type
5 Global Pressurized Metered Dose Inhaler Historic Market Analysis by Application
6 Key Companies Profiled
7 Pressurized Metered Dose Inhaler Manufacturing Cost Analysis
8 Marketing Channel, Distributors and Customers
9 Pressurized Metered Dose Inhaler Market Dynamics
10 Global Market Forecast
11 Research Finding and Conclusion
12 Methodology and Data Source
Company Name: The Market Reports
Contact Person: Shirish Gupta
Erik Brady is a news media and fitness professional with a strong experience in online journalism as well as he is a well-known fitness instructor. He strength includes knowledge of sports, health, yoga, meditation, and proficiency. From a young age, Erik has interest in Football and he is BundesPremierLeague Contributor.